Another $8 Billion Pharma/Oncology deal!, page-21

Hi All &@Kates9999,

thanks for all your efforts here Kate, Biotechs are being bought out post 1b trials, I wish people would stop saying “it’s too early or their trials are too small”, especially in cancer breakthroughs.  

JBM week is a really big deal for Biotechs & wishing Leslie & team the best of luck.

so Loxo-292 has a couple of indications in thyroid & lung cancer:

https://www.curetoday.com/articles/loxo292-granted-breakthrough-therapy-designation-for-lung-and-thyroid-cancer

I think the clincher on this $8 billion dollar deal, being awarded Breakthrough therapy designation from the FDA for big Pharma, post Ph1.  

Read what you do, share it, know what you know, accept that Biotechs are a risk, but the IMU story is just getting better & bigger.  We may have to wait, but willing to take that risk & glad I bought more at .018 last week.

GLTAH